Pro Medicus (ASX:PME) signs $31m contract with in the US

Company News

by Rachael Jones

Leading health imaging company Pro Medicus (ASX:PME) today announced its wholly owned US subsidiary, Visage Imaging, Inc., has signed a 7-year contract worth $31 million.

The contract, based on a transactional licensing model, will see the company’s Visage 7 Viewer implemented across five diagnostic imaging departments, the first time the entire system will be unified on a single diagnostic imaging platform.

The academic health systems are UC Los Angeles, UC San Francisco, UC San Diego, UC Davis and UC Irvine.

This was a highly sought after and extremely competitive tender.

Planning for the rollout is to commence immediately.

Shares in Pro Medicus (ASX:PME) are trading 0.87 per cent lower at $46.61.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.